SCHEMBL24767636

SCHEMBL24767636

COc1cccc(Cc2csc([C@H](Cc3ccc(N[SH](=O)=O)cc3)NC(=O)C(C)(C)C)n2)c1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19775472 0.89 PTPRB (0.65) PTPRB
SCHEMBL19775413 0.88 PTPRB (0.75) PTPRB
SCHEMBL467958 0.88 PTPRB (1.00) PTPRB
SCHEMBL19775480 0.86 PTPRB (0.78) PTPRB
SCHEMBL27856710 0.85 PTPRB (0.77) PTPRB
SCHEMBL19775556 0.83 PTPRB (0.78) PTPRB
SCHEMBL19775492 0.82 PTPRB (0.74) PTPRB
SCHEMBL19775220 0.82 PTPRB (0.74) PTPRB
SCHEMBL19775541 0.82 PTPRB (0.59) PTPRB
SCHEMBL19775590 0.81 PTPRB (0.79) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4101297-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Pharmaceuticals, Inc. (US) 2022-12-14 EP disclosed